1986
$450M
from 7 investors over 7 rounds
BioCryst Pharmaceuticals, Inc. raised $450M on April 17, 2023
Investors: Pharmakon Advisors, LP
BioCryst Pharmaceuticals, Inc. raised $350M on November 22, 2021
Investors: Royalty Pharma and OMERS
BioCryst Pharmaceuticals, Inc. raised $325M on December 7, 2020
Investors: Athyrium Capital Management, LP and Royalty Pharma
BioCryst Pharmaceuticals, Inc. raised $100M on February 7, 2019
Investors: MidCap Financial
BioCryst Pharmaceuticals, Inc. raised $35M on September 6, 2018
Investors: CDC